The eighth annual Traumatic Brain Injury (TBI) Conference, May 16-17 at the Westin Arlington Gateway in Washington, DC, will feature more than 25 speakers and 30 presentations and panel discussions addressing several TBI focus areas.
These focus areas will include: clinical trials, neurodegeneration and TBI, CTE pathobiology, TRACK-TBI, outcomes research, blood biomarkers, point of care diagnostics, neuroimaging, classification, and preclinical research.
The TBI Conference brings together physicians, nurses, neurosurgeons, scientists, and drug-diagnostic developers from all over the world to present original research and analysis aimed at providing a full picture of the progress being made toward better diagnosis, treatment, and long-term care for TBI survivors.
“We’re proud to have the brightest minds in TBI research presenting their recent findings and sharing in panel discussions,” says John Waslif, managing director of Arrowhead Publishers, organizer of the TBI Conference, in a media release.
“The science surrounding brain injury treatment and recovery is advancing at such a rapid pace that this forum for collaboration is rich with opportunity to identify efficiencies and solutions that improve outcomes for brain injury survivors.”
[Source(s): Arrowhead Publishers, PRWeb]
